Firnges; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Firnges; Michael.The latest application filed is for "pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators".

Company Profile

0.5.9

Firnges; Michael - Barsinghausen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions Grant 8,058,264 - Firnges , et al. November 15, 2	2011-11-15
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions Grant 7,772,225 - Antel , et al. August 10, 2	2010-08-10
Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators Grant 7,763,607 - Antel , et al. July 27, 2	2010-07-27
NK1 and NK2-antagonists and compositions and methods of using the same Grant 7,592,344 - Antel , et al. September 22, 2	2009-09-22
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof Grant 7,547,708 - Antel , et al. June 16, 2	2009-06-16
Use of CBx cannabinoid receptor modulators as potassium channel modulators App 20070254863 - Antel; Jochen ; et al.	2007-11-01
Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators App 20070254862 - Antel; Jochen ; et al.	2007-11-01
Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation App 20070219214 - Jasserand; Daniel ; et al.	2007-09-20
Methods Of Using Potassium Channel Inhibiting Compounds App 20070191357 - Antel; Jochen ; et al.	2007-08-16
N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions App 20070149512 - Antel; Jochen ; et al.	2007-06-28
NK1 and NK2-antagonists and compositions and methods of using the same App 20070149537 - Antel; Jochen ; et al.	2007-06-28
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof App 20070117823 - Antel; Jochen ; et al.	2007-05-24
Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions App 20060128673 - Firnges; Michael ; et al.	2006-06-15
Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions App 20050261292 - Antel, Jochen ; et al.	2005-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.